Since September 2005, Doug DeVeny has been a member of the Global Engineering organization for
Genentech. He provides management and technical leadership in the architectural, electrical, mechanical,
and civil/structural disciplines for the design, construction, start-up and qualification of Genentech and
Roche capital facility projects around the world. He is currently responsible for developing and
implementing design standards and guidelines for administrative, research and development, and
manufacturing facilities, with a focus on cost effective engineering solutions. In addition, Doug provides
corporate guidance for capital projects in the area of sustainable design.
Previously, as Manager of Architecture at Jacobs Engineering in Cincinnati, Ohio, Doug led architects and
designers in the conceptual design through construction support of multiple pharmaceutical-related
projects. Prior to his management role at Jacobs Engineering, he was a project architect at a variety of
architectural firms specializing in the design of commercial facilities.
Doug has over 34 years of professional practice in architectural engineering design for pharmaceutical
manufacturing, laboratory, chemical process, medical, office, commercial, educational and residential
projects. He has extensive experience providing programming, master planning, design and construction
support for a variety of pharmaceutical clients, including Genentech, Roche, Wyeth, Eli Lilly, Abbott,
Genzyme, BioMarin, Amgen, Pfizer and Bayer. He also periodically presents and contributes to publications,
as well as initiatives, for organizations such as BPOG, CLSA (formerly BayBio), ASHRAE, ISPE, Corporate
Realty Design & Management Institute, CoreNet, and CIDCI. Doug is a licensed architect in several states,
including California, with a B.Arch degree from the University of Cincinnati.